Cancer Risk, Unexpected Benefit
1:12:16–1:12:54 · 38s
In an MDS-to-AML mouse model, augmenting stem cells with mitochondria didn’t accelerate leukemia—it extended lifespan and delayed progression.
1:12:16–1:12:54 · 38s
In an MDS-to-AML mouse model, augmenting stem cells with mitochondria didn’t accelerate leukemia—it extended lifespan and delayed progression.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.